Virpax Pharmaceuticals, Inc.·4

Feb 19, 6:22 PM ET

JACOB GARY S 4

4 · Virpax Pharmaceuticals, Inc. · Filed Feb 19, 2021

Insider Transaction Report

Form 4
Period: 2021-02-17
JACOB GARY S
Director
Transactions
  • Purchase

    Common Stock, $0.00001 par value

    2021-02-17$6.79/sh+3,500$23,7623,500 total
Footnotes (1)
  • [F1]This transaction was executed in multiple trades. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file
  • 4
    ownership.xmlPrimary